Morgan Stanley Raises its Price Target on Alnylam (ALNY)
Morgan Stanley Raises its Price Target on Alnylam (ALNY).
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 10 Best Growth Stocks With Highest Upside Potential .
On July 10, 2026, Morgan Stanley raised the firm's price target on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) to $400 from $370 and kept an Equal Weight rating on the shares.
On July 9, Raymond James raised the firm's price target on Alnylam to $468 from $420 and kept an Outperform rating on the shares. Raymond James said Ionis' (IONS) failed Phase 3 ATTR-CM trial strengthens Alnylam's competitive position by reducing a key rival to its TTR silencer franchise and improving the outlook for pricing. The firm also noted that the results may raise some risk for Alnylam's next-generation nucresiran trial in patients receiving background tafamidis.
On June 29, H.C. Wainwright lowered the firm's price target on Alnylam to $470 from $510 and kept a Buy rating on the shares. H.C. Wainwright reduced near-term estimates for Amvuttra but continued to estimate Alnylam's TTR franchise growing to over $20B in annual revenues by 2040.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
While we acknowledge the potential of ALNY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy .
Sinergia Empresarial continuará el seguimiento de esta información sobre morgan Stanley Raises its Price Target on Alnylam (ALNY) y ampliará la cobertura conforme se confirmen nuevos elementos relevantes para el ecosistema empresarial.
